These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 16541329)
1. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. Newton HB; Goldlust SA; Pearl D J Neurooncol; 2006 May; 78(1):99-102. PubMed ID: 16541329 [TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. Newton HB; Dalton J; Goldlust S; Pearl D J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440 [TBL] [Abstract][Full Text] [Related]
4. Use of levetiracetam in hospitalized patients. Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722 [TBL] [Abstract][Full Text] [Related]
5. Levetiracetam monotherapy--outcomes from an epilepsy clinic. Stephen LJ; Kelly K; Parker P; Brodie MJ Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583 [TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651 [TBL] [Abstract][Full Text] [Related]
7. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. Lee JW; Alam J; Llewellyn N; Hurwitz S; Bubrick EB; Sarkis RA; Weisholtz D; Yu H; Putta S; Dworetzky BA; Pennell PB Clin Neuropharmacol; 2016; 39(3):128-31. PubMed ID: 26992155 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam monotherapy for elderly patients with epilepsy. Alsaadi TM; Koopmans S; Apperson M; Farias S Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184 [TBL] [Abstract][Full Text] [Related]
9. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820 [TBL] [Abstract][Full Text] [Related]
10. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Glien M; Brandt C; Potschka H; Löscher W Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764 [TBL] [Abstract][Full Text] [Related]
11. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311 [TBL] [Abstract][Full Text] [Related]
12. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [TBL] [Abstract][Full Text] [Related]
13. Levetiracetam therapy in patients with brain tumour and epilepsy. Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465 [TBL] [Abstract][Full Text] [Related]
14. Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs. Wychowski T; Wang H; Buniak L; Henry JC; Mohile N Clin Neurol Neurosurg; 2013 Nov; 115(11):2365-9. PubMed ID: 24054994 [TBL] [Abstract][Full Text] [Related]
15. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Rocamora R; Wagner K; Schulze-Bonhage A Seizure; 2006 Sep; 15(6):428-33. PubMed ID: 16837220 [TBL] [Abstract][Full Text] [Related]
16. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730 [TBL] [Abstract][Full Text] [Related]
17. Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. Zachenhofer I; Donat M; Oberndorfer S; Roessler K J Neurooncol; 2011 Jan; 101(1):101-6. PubMed ID: 20526797 [TBL] [Abstract][Full Text] [Related]
18. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D; Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439 [TBL] [Abstract][Full Text] [Related]
19. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study. Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]